|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.389 EUR | -0.13% |
|
-1.27% | -15.43% |
| May. 07 | GenSight Biologics S.A. announced that it expects to receive ?1.546199 million in funding | CI |
| Apr. 05 | GenSight: financial visibility assured until the end of April | CF |
Attachments
Disclaimer
Gensight Biologics SA published this content on 06 May 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 06 May 2024 16:32:03 UTC.
| 1st Jan change | Capi. | |
|---|---|---|
| -15.43% | 42.92M | |
| +12.30% | 118B | |
| +12.15% | 106B | |
| -8.14% | 23.4B | |
| -0.29% | 21.78B | |
| -9.28% | 18.09B | |
| -41.70% | 16.72B | |
| -15.33% | 15.97B | |
| +5.80% | 14.03B | |
| +28.03% | 11.67B |
GENSIGHT BIOLOGICS S.A. 
